Professor Mehra Golshen will participate this year in the Surgical Oncology course held in the BGICC 2020
He is the Director of the Breast Surgical Oncology Fellowship at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School.
He chairs the Dana Farber/Brigham and Women’s Cancer Center: Committee for the American College of Surgeon’s Commission on Cancer and serves as the Cancer Liaison Physician as well.
He is studying the use of intra-operative diagnostic biomarkers and tools in BWH’s Advanced Multimodality Image Guided Operative Suite to determine if they can identify and remove residual tumor with the aim of improving patient outcomes and reducing re-excision rates.
Dr. Golshan is also a leading researcher on tailoring the extent of surgery and therapy for women with early-stage breast cancer.
Dr. Golshan has been consistently named one of America’s Top Doctors by Castle Connolly and named a top surgeon in Boston Magazine.